PHENYLALANINE

Molecular Excipient

Mwt. LogP HBD HBA PSA RB CSP3
165.0 0.6 2 2 63.0 3 0.22
CAS
63912
UNII
47E5O17Y3R
SYNONYMS
ZINC ID(s)
Availability
Present in 104 ZINC catalogs

Known Active Genes

This compound has been observed to have activity at 10μM or less against the following gene(s).
Name Description Classification
CACNA2D1 Voltage-dependent calcium channel subunit alpha-2/delta-1 Auxiliary Transport Protein / Atp-Ca-A2d

Clinical Trials

This compound has been an intervention in the following clincial trials (per clinicaltrials.gov).
Code Date Title Phase Status
NCT01376908 2011-06-01 KuvanĀ® in Phenylketonuria Patients Less Than 4 Years Old Phase 3 Active, Not Recruiting
NCT01233492 2007-10-01 Boron Phenylalanine With or Without Mannitol in Treating Patients With Glioblastoma Multiforme Phase 1 Terminated

(Browse) Purchasable Analogs in ZINC

Dosages

Route Formulation Per Unit Dose
Iv(Infusion) Injection 52.6%
Iv(Infusion) Solution, Injection 0.17%

More Information

Usage Over Time

Comments